Stanford Comprehensive Epilepsy Program Clinical Trials

A First-in-human Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)
PI: Kevin Graber, MD
NCT05135091
Study Status: Enrolling
Research Coordinator: Jordan Seliger
Contact: jseliger@stanford.edu

Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)
PI: Kevin Graber, MD
NCT03900468
Study Status: Enrolling
Research Coordinator: Jordan Seliger
Contact: jseliger@stanford.edu

Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)
PI: Kimford Meador, MD
NCT01730170
Study Status: Closed to Enrollment
Research Coordinator: Jordan Seliger
Contact: jseliger@stanford.edu

Electrophysiological Biomarkers of Consciousness in Patients with Epilepsy and Patients with Psychogenic Non-Epileptic Spells
PI: Kimford Meador, MD
Study Status: Enrolling
Research Coordinator: Jordan Seliger
Contact: jseliger@stanford.edu

Electroencephalographic Biomarkers of Neuro-Cognitive Function
PI: Kimford Meador, MD
Study Status: Enrolling
Research Coordinator: Jordan Seliger
Contact: jseliger@stanford.edu

Using Artificial Intelligence to Choose the Optimal Antiepileptic Drug
Protocol ID : 46059
PI: Robert S. Fisher, MD, PhD
Status: Enrolling subjects

Transcranial Direct Current Stimulation to Treat Epilepsy
Protocol ID : 47711
PI: Robert S. Fisher, MD, PhD
Status: Enrolling subjects             

Focused ultrasound to treat epilepsy (EP001)
Protocol ID : 55981
PI: Robert S. Fisher, MD, PhD
Status: Enrolling subjects

AI-Guided 3D Video Analysis for Seizure Detection
Protocol ID : 53035
PI: Robert S. Fisher, MD, PhD
Status: Pending loosening of COVID travel requirements

Cognitive Effects of Vinpocetine in Patients with Epilepsy
PI: Kimford Meador, MD
NCT02011971
Study Status: Closed to Enrollment
Research Coordinator: Jordan Seliger
Contact: jseliger@stanford.edu

Effects of Titration Rate on Cognitive and Behavioral Side Effects of Perampanel
PI: Kimford Meador, MD
NCT04417907
Study Status: Closed to Enrollment
Research Coordinator: Jordan Seliger
Contact: jseliger@stanford.edu

RNS® System Post-Approval Study in Epilepsy Clinical Investigational Plan (CIP)
PI: Babak Razavi
NCT02403843
Study Status: Closed to enrollment
Research Coordinator: Jordan Seliger, Adele Viviani
Contact: jseliger@stanford.edu or aviviani@stanford.edu

Personal Impact of Epilepsy Scale (PIES): Determining the Minimally Important Change
Protocol ID : 43107
PI: Robert S. Fisher, MD, PhD
Status: Closed, in data analysis phase

Evaluation of the 24/7 EEG SubQ System for Ultra Long-Term Recording of Patients with Temporal Lobe Epilepsy
PI: Babak Razavi
NCT04526418
Study Status: Enrolling Soon
Research Coordinator: Jordan Seliger, Adele Viviani
Contact: jseliger@stanford.edu or aviviani@stanford.edu

Open-label, Multi-center, Phase 1/2a Observational, First-in-human (FIH) Study Investigating the Safety and Efficacy of AMT-260 in Adult Subjects with Refractory Mesial Temporal Lobe Epilepsy (MTLE) in the Non-Dominant Hemisphere Administered via Magnetic Resonance Imaging (MRI) guided Convection-enhanced Delivery (CED) (CT-AMT-260-01)
PI: Yi Li
NCT0603850
Study Status: Enrolling Soon
Research Coordinator: Jordan Seliger, Adele Viviani
Contact: jseliger@stanford.edu or aviviani@stanford.edu

A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy
PI: Yi Li
NCT06132893
Study Status: Enrolling Soon
Research Coordinator: Jordan Seliger, Adele Viviani
Contact: jseliger@stanford.edu or aviviani@stanford.edu

For more information on our clinical trials

Research Coordinator: Jordan Seliger
jseliger@stanford.edu